INDICATION
CUVITRU is a ready-to-use liquid medicine that is given under the skin (subcutaneously) to treat primary immunodeficiency (PI) in people 2 years and older.
Short-term but serious infections that require immediate medical care
Proteins made by the body to help fight infections
Disease or condition that usually lasts for 3 months or longer and may get worse
over time
Helps your body fight infection
Method of administering fluids into the bloodstream
Occur on the body where the medicine is given; these generally go away within a few hours and are less likely after the first few infusions
Patient experience in a clinical trial over the course of 1 year. One patient-year is equal to, for example, the experience of 2 patients for 6 months, or 12 patients for 1 month each
A term used to describe a group of mostly genetic disorders that cause the immune system to not work correctly
Under the skin
Happen throughout the body, such as a headache or feeling tired